Potential therapeutic significance of increased expression of aryl hydrocarbon receptor in human gastric cancer

doi:10.3748/wjg.15.1719

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4232)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series, Tables (1-6) series.

Item

Count

PDF

411

HTML

3413

Figures (1-8)

246

Tables (1-6)

162

Sum=4232

Apr 14, 2009 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (32)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Articles

World J Gastroenterol. Apr 14, 2009; 15(14): 1719-1729
Published online Apr 14, 2009. doi: 10.3748/wjg.15.1719

Full Size Figure Download Figure

Figure 4 AhR and CYP1A1 expression in AGS cells after TCDD treatment. A and B: RT-PCR; C and D: Western blotting. Treatment of AGS cells with specific AhR agonist TCDD resulted in a dose- (A and C) and time-dependent (B and D) induction of CYP1A1 expression. The results shown are representative of three independent experiments.

Citation: Peng TL, Chen J, Mao W, Liu X, Tao Y, Chen LZ, Chen MH. Potential therapeutic significance of increased expression of aryl hydrocarbon receptor in human gastric cancer. World J Gastroenterol 2009; 15(14): 1719-1729
URL: https://www.wjgnet.com/1007-9327/full/v15/i14/1719.htm
DOI: https://dx.doi.org/10.3748/wjg.15.1719